The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab

BACKGROUND: It is not well known to what extent effectiveness of treatment with immune checkpoint inhibitors in stage IV non‐small‐cell lung cancer (NSCLC) is influenced by weight loss and changes in body composition. Therefore, the goal of this study was to evaluate body composition changes in rela...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cachexia Sarcopenia Muscle
Main Authors: Degens, Juliette H.R.J., Dingemans, Anne‐Marie C., Willemsen, Anna C.H., Gietema, Hester A., Hurkmans, Daan P., Aerts, Joachim G., Hendriks, Lizza E.L., Schols, Annemie M.W.J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8200425/
https://ncbi.nlm.nih.gov/pubmed/33951326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12698
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados